Table 2.
Target gene | No PreAmp Avg Cq | % Expression in RA treated cells relative to control cells |
---|---|---|
T (Brachyury) | 34.1 | 1% |
OTX2 | 27.4 | 6% |
DKK1 | 32.2 | 10% |
NANOG | 23.7 | 18% |
DPPA3 | 29.7 | 22% |
MIXL1 | 30.0 | 23% |
TDGF1 | 24.6 | 23% |
RARG | 29.4 | 23% |
PRDM14 | 26.3 | 24% |
CD44 | 28.6 | 25% |
PMAIP1 | 25.6 | 25% |
POU5F1 | 21.0 | 26% |
SOX9 | 27.6 | 27% |
CA12 | 29.8 | 28% |
THY1 | 24.5 | 47% |
DLL3 | 28.8 | 307% |
SNCG | 26.8 | 404% |
GABRB2 | 29.1 | 493% |
CRABP2 | 20.0 | 831% |
POU3F2 | 29.7 | 1280% |
CDX1 | 30.1 | 1801% |
MEIS1 | 28.6 | 1879% |
RARB | 28.6 | 1884% |
HOXD4 | 29.3 | 3074% |
ASCL1 | 28.6 | 3141% |
HNF4A | 31.5 | 3507% |
LEFTY2 | 25.1 | 6656% |
NEUROG2 | 33.2 | 8626% |
FOXA1 | 33.3 | 9277% |
HOXA4 | 33.5 | 10550% |
PAX6 | 27.7 | 13467% |
NEUROD1 | 35.2 | 13703% |